INHIBITOR: Retrospective Study Of Patients With Renal Cell Carcinoma And Mantle Cell Lymphoma Treated With Temsirolimus

NCT01367457 · clinicaltrials.gov ↗

COMPLETED

Status

243

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Renal Cell
Lymphoma, Mantle-Cell

Interventions

OTHER: Temsirolimus (Non-Interventional Study)

Sponsor

Pfizer